NEW YORK, May 27 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and clinicians and other stakeholders to highlight opportunities and discuss advances in the stem cell field.
Alan Harris, M.D., Ph.D., NeoStem's VP of Regenerative Medicine, Drug Development and Regulatory Affairs, has been selected to participate in the 11:30 am ET panel discussion on "Adult versus Embryonic" stem cells. Dr. Harris will highlight the positive attributes of and advances in adult stem cell research, as well as discuss the regenerative properties of very small embryonic-like stem cells without the controversy of traditional embryonic stem cells. The panel will be moderated by Martin Grumet, Ph.D., Professor of Cell Biology and Neuroscience, Division of Life Sciences, at Rutgers University. Additional panel participants will include Michael West, Ph.D., CEO of BioTime, Inc., and Michael Schuster, VP of Operations at Angioblast System, Inc.
At a 2:00 pm ET plenary session,
|SOURCE NeoStem, Inc.|
Copyright©2010 PR Newswire.
All rights reserved